Page last updated: 2024-11-01

niclosamide and Respiratory Syncytial Virus Infections

niclosamide has been researched along with Respiratory Syncytial Virus Infections in 2 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Respiratory Syncytial Virus Infections: Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Xu, J1
Wu, W1
Chen, H1
Xue, Y1
Bao, X1
Zhou, J1
Niyomdecha, N1
Suptawiwat, O1
Boonarkart, C1
Thitithanyanont, A1
Auewarakul, P1

Other Studies

2 other studies available for niclosamide and Respiratory Syncytial Virus Infections

ArticleYear
Substituted N-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues potently inhibit respiratory syncytial virus (RSV) replication and RSV infection-associated inflammatory responses.
    Bioorganic & medicinal chemistry, 2021, 06-01, Volume: 39

    Topics: A549 Cells; Antiviral Agents; Benzamides; Humans; Inflammation; Respiratory Syncytial Virus Infectio

2021
Repurposing of antiparasitic niclosamide to inhibit respiratory syncytial virus (RSV) replication.
    Virus research, 2021, 04-02, Volume: 295

    Topics: Antiparasitic Agents; Antiviral Agents; Drug Repositioning; Humans; Mechanistic Target of Rapamycin

2021